NasdaqCM - Delayed Quote USD
Alpha Tau Medical Ltd. (DRTSW)
0.2300
0.0000
(0.00%)
As of April 23 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
36,042
36,042
35,680
32,136
13,790
Operating Income
-36,042
-36,042
-35,680
-32,136
-13,790
Net Non Operating Interest Income Expense
3,933
3,933
4,716
1,769
195
Other Income Expense
365
365
1,823
-3,375
-13,669
Pretax Income
-31,744
-31,744
-29,141
-33,742
-27,264
Tax Provision
6
6
16
20
7
Net Income Common Stockholders
-31,750
-31,750
-29,157
-33,762
-27,271
Diluted NI Available to Com Stockholders
-31,750
-31,750
-29,157
-33,762
-27,271
Total Operating Income as Reported
-36,042
-36,042
-35,680
-32,136
-13,790
Total Expenses
36,042
36,042
35,680
32,136
13,790
Net Income from Continuing & Discontinued Operation
-31,750
-31,750
-29,157
-33,762
-27,271
Normalized Income
-32,031.0500
-32,031.0500
-30,560.7100
-31,163.2500
-16,745.8700
Interest Income
4,277
4,277
4,830
1,790
211
Interest Expense
303
303
75
--
--
Net Interest Income
3,933
3,933
4,716
1,769
195
EBIT
-31,441
-31,441
-29,066
-33,742
-27,264
EBITDA
-30,339
-30,339
-27,992
-32,763
-26,488
Reconciled Depreciation
1,102
1,102
1,074
979
776
Net Income from Continuing Operation Net Minority Interest
-31,750
-31,750
-29,157
-33,762
-27,271
Total Unusual Items Excluding Goodwill
365
365
1,823
-3,375
-13,669
Total Unusual Items
365
365
1,823
-3,375
-13,669
Normalized EBITDA
-30,704
-30,704
-29,815
-29,388
-12,819
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
83.9500
83.9500
419.2900
-776.2500
-3,143.8700
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ESLAW Estrella Immunopharma, Inc.
0.0885
+5.11%
CELUW Celularity Inc.
0.0376
+4.44%
CINGW Cingulate Inc.
0.0331
0.00%
TVGNW Tevogen Bio Holdings Inc.
0.0492
-0.81%
TCBPY TC Biopharm (Holdings) Plc
0.4500
+45.16%
QLGN Qualigen Therapeutics, Inc.
3.7881
-1.61%
ABUS Arbutus Biopharma Corporation
3.2750
+1.08%
TLSA Tiziana Life Sciences Ltd
1.4300
+9.16%
BBIO BridgeBio Pharma, Inc.
35.69
+1.31%
MAIA MAIA Biotechnology, Inc.
1.9800
-3.41%